The shoe’s breathable Matryx upper contains Kevlar, along with 3D-printed and TPU overlays, for top-of-the-line abrasion ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...